14.14
+0.2(+1.43%)
Currency In USD
| Previous Close | 13.94 |
| Open | 13.89 |
| Day High | 14.17 |
| Day Low | 13.41 |
| 52-Week High | 24.5 |
| 52-Week Low | 8.89 |
| Volume | 738,643 |
| Average Volume | 513,693 |
| Market Cap | 613.06M |
| PE | -8.62 |
| EPS | -1.64 |
| Moving Average 50 Days | 15.1 |
| Moving Average 200 Days | 15.93 |
| Change | 0.2 |
Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025
GlobeNewswire Inc.
Yesterday at 11:30 AM GMT
IRVINE, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its second quarter 2025 financial result
Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor
GlobeNewswire Inc.
Jun 19, 2025 11:00 AM GMT
IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its iLet Bionic Pancreas automated insulin delivery (AID) s
Beta Bionics to Present at the Bank of America Securities Health Care Conference
GlobeNewswire Inc.
May 01, 2025 12:00 PM GMT
IRVINE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at the Bank of America Securities Hea